| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |